Private capital backs Vertice MedTech to power 7,000 surgeries monthly across Southern Africa

Private capital consortium comprising Amethis, Proparco, ccap.ai and management has completed an investment in African MedTech firm, Vertice MedTech Holdings, positioning the fast-growing healthcare technology firm for its next phase of expansion.

The deal backs Vertice’s executive team, led by Hendri Pretorius, to accelerate growth across its core medical device and digital health businesses, while expanding into new markets across Africa and Europe.

Driving healthcare innovation and access

Founded in 2018 in partnership with Ethos Private Equity, Vertice has grown into Southern Africa’s leading independent distributor of specialized medical devices, while emerging as a pioneer in healthcare software and mobile health solutions.

The company operates more than 780 employees across distribution hubs in Pretoria, Durban, and Cape Town, alongside regional centers in Port Elizabeth, George, and Bloemfontein. Through exclusive partnerships with global manufacturers including Abbott, Stryker and Haemonetics, Vertice delivers advanced medical technologies across cardiovascular, urology, orthopaedics, and spine segments. Vertice operates two core divisions: Vertice Healthcare, focused on medical devices, and Vertice Software, which develops AI-driven digital health solutions delivered through a scalable SaaS model.

Scaling impact through technology

By enabling more than 7,000 surgeries monthly, Vertice plays a critical role in strengthening healthcare systems and improving patient outcomes across Southern and Sub-Saharan Africa. Its integrated model supports earlier diagnosis, reduces disease burden, and enhances healthcare delivery efficiency.

The new investment will fund organic expansion, deepen market penetration, and support entry into new geographies. The company also plans to scale its software division into Europe while pursuing selective mergers and acquisitions aligned with its growth strategy.

Strategic backing for next growth phase

Pretorius said the partnership marks the launch of “Vertice 2.0,” highlighting the consortium’s sector expertise and global networks as key to accelerating expansion. Amethis Managing Director Marieke Geurts noted the company’s positioning at the intersection of medical devices and digital health as a key driver of long-term impact and growth.

Proparco’s Tibor Asboth added that the investment aligns with its mandate to support high-impact businesses that expand access to quality healthcare, while ccap.ai partner Willem Roos emphasized the transformative role of data-driven platforms in reshaping healthcare delivery, particularly in underserved markets. The transaction underscores rising investor interest in scalable, tech-enabled healthcare platforms addressing access gaps across emerging markets, as Vertice positions itself as a leading player in Africa’s evolving health technology ecosystem.